QI Power Hour: Vaccine and Infectious Disease Organization (VIDO) (Mar. 23/21)

The University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) has been a leader in COVID-19 research and development since the emergence of SARS-CoV-2. This includes being the first in Canada to isolate the virus, the first in Canada to develop an animal model, and the first Canadian university organization to have a vaccine in clinical trials. In this webinar you will: • Learn more about VIDO’s COVID-19 response • Find out about vaccine development during a pandemic, and • Hear about VIDO’s aims to improve Canada’s pandemic preparedness. Presenter: Dr. Volker Gerdts, Director and CEO of VIDO